Sheila Gujrathi - Jan 21, 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Director
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol: VTYX
Transactions as of: Jan 21, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/23/2024, 05:00 PM
Previous filing: Jun 16, 2023
Next filing: Mar 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (Right to Buy)	Award	$0	+80K		$0.00	80K	Jan 21, 2024	Common Stock	80K	$1.97	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest on the one-year anniversary of January 21, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan, the "Plan") through such date, provided that in the event of a Change in Control (as such term is defined in the Plan), one hundred percent (100%) of the then-unvested and outstanding shares subject to the Option will accelerate and fully vest, subject to the reporting person continuing to be a Service Provider through the date of the Change in Control.

Content

The shares subject to the option shall vest on the one-year anniversary of January 21, 2024, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan, the "Plan") through such date, provided that in the event of a Change in Control (as such term is defined in the Plan), one hundred percent (100%) of the then-unvested and outstanding shares subject to the Option will accelerate and fully vest, subject to the reporting person continuing to be a Service Provider through the date of the Change in Control.